Navigation Links
The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
Date:7/9/2008

- Surfing Becomes First Sport To Mitigate the Impact of a Disease

- Surfing Legends Laird Hamilton and Dave Kalama Co-Host Inaugural Gala to Raise Research Funds

HUNTINGTON BEACH, Calif., July 9 /PRNewswire-USNewswire/ -- Amazingly, surfers have unknowingly held a key to prolonging the lifespan and quality of life for people with cystic fibrosis (CF), a fatal genetic disease that causes the body to produce thick, sticky mucus, which clogs the lungs and leads to life-threatening lung infections.

Several years ago, doctors in Australia noticed young surfers with cystic fibrosis had significantly healthier lungs. The doctors determined that inhaling saltwater mist has a powerful effect on rehydrating the lining of the lungs and allowing CF patients to more easily eliminate bacteria-contaminated mucus. This discovery led researchers to develop a hypertonic saline solution, which CF patients around the world now inhale every day. In essence, CF patients now mimic a "surf session" on a daily basis.

More than 70,000 CF patients face a daily battle, enduring hours of daily therapies and treatments to avoid the threat of mucus build-up in the lungs. While average life expectancy has doubled in the past 25 years to age 37 -- due to advances in treatment and care -- funding is still urgently needed to find the miracle drug leading to a cure.

The recent "saltwater" breakthrough treatment has led the Southern California Chapter of the Cystic Fibrosis Foundation to form a "PIPELINE TO A CURE" campaign to raise funds and to bring about global awareness of the unique bond between the sport of surfing and those with cystic fibrosis.

On July 19, 2008, the Cystic Fibrosis Foundation together with honorary co-chairs and surf legends Laird Hamilton and Dave Kalama will host an inaugural gala at the Hyatt Regency Huntington Beach, California, also known as "Surf City."

Title sponsor PacSun and supporting sponsors the Kelly Slater Fo
'/>"/>

SOURCE Cystic Fibrosis Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
2. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
3. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
4. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
5. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
6. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
7. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
8. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
9. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
10. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
11. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... Capacity and Production" report to their offering. ... Survey of Biopharmaceutical Manufacturing Capacity and Production is ... contract manufacturing organizations, current and projected future capacity ...
(Date:8/28/2015)... , Aug. 28, 2015  Today, in final ... (CDC) Contact Lens Health Week, 1-800 Contacts is sharing ... found that contact lens wearers who do not properly ... risk for eye infections. Most contact ... lenses, but a clean lens case is sometimes overlooked.  ...
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Quetiapine Market, 2010-2019" ... by AstraZeneca plc, quetiapine (under the trade name ... treatment of schizophrenia. Approved by CFDA to treat ... Catalogue of Drugs for the Basic National Medical ...
Breaking Medicine Technology:12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 21-800 Contacts Shares Tips on How to Clean Lens Cases 2China Quetiapine Market Investigation Report 2010-2019 2
... Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care ... and chief executive officer,  will present at the Citi ... Markets, 2012 Healthcare Conference. The Citi conference ... 11:30 a.m. ET. The Citi conference will be held ...
... Feb. 23, 2012 Vanda Pharmaceuticals Inc. (Vanda) ... focused on the development and commercialization of products ... today announced that it will participate in three ... 28, 2012, Mihael Polymeropoulos, M.D., Vanda,s President and ...
Cached Medicine Technology:Abaxis, Inc. to Present at the Citi 2012 Global Health Care Conference and RBC Capital Markets' 2012 Healthcare Conference 2Abaxis, Inc. to Present at the Citi 2012 Global Health Care Conference and RBC Capital Markets' 2012 Healthcare Conference 3Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences 2
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... to insufficient scrotal support and protection against dribbled urine and sweat. "In order ... Manhasset Hills, N.Y. , The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal ...
(Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor Day ... astronomically, officially ends on September 22nd this year). For IT security personnel, it should ... on which could prove far more costly than a simple headache. , Joe Caruso, ...
(Date:8/29/2015)... ... August 29, 2015 , ... The popular television program VOICES IN AMERICA, hosted ... it will be devoting an entire short segment to the subject of diabetes. Diabetes ... globe on a daily basis, but recent advancements in medical science may prove to ...
(Date:8/28/2015)... ... August 28, 2015 , ... An online provider of CPAP machines, masks, supplies, ... CPAP equipment more affordable by offering shipping at no cost to you, directly to ... orders of any size. My Cpap Store is located in Las Vegas, Nevada. , ...
(Date:8/28/2015)... , ... August 28, 2015 , ... With the goal ... returned for the second year to the Adams County Fairgrounds in Mendon, IL on ... to raise money to support music education in the underfunded school districts of Mendon ...
Breaking Medicine News(10 mins):Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2
... InPlace Medical Solutions(TM) secures 24/7 physician access to ... 11 InPlace Medical Solutions, the first full-service ... another first in the offshore medical industry - ... telemedicine for its clients. All services are ...
... Co., Inc., (NYSE Amex: TPI ), a ... in Chengdu, China, today,announced that management will hold a ... 11:00 a.m. EDT on Friday, May 15, 2009. Financial,results ... market closes. , Interested parties ...
... of Christopher Reeve to run on behalf of 1.275 million ... The Christopher & Dana Reeve Foundation today announced Matthew ... of Directors of the Reeve Foundation, will run the 2009 ... Team Reeve, Matthew was inspired to compete on behalf of ...
... cancer, undergoing a radical prostatectomy can greatly increase their ... from Henry Ford Hospital. , Results from the study ... surgical procedure improves the 5-, 10-, 15- and 20-year ... treatments such as radiotherapy or watchful waiting. , "When ...
... Transplanted embryonic stem cells are recognized as a potential ... cord injury (SCI). However, in studies using embryonic stem ... has been the development of tumors following transplantation. ... Transplantation (Vol. 18 No.1), a team of Japanese ...
... 11 Palomar Medical Technologies, Inc. (Nasdaq: ... systems for cosmetic treatments, announced today that it has ... QUA), a leading manufacturer of solid state lasers, for ... in the United States and Canada.The SINON Q-switched ruby ...
Cached Medicine News:Health News:The Doctor Is In, Around the Clock 2Health News:The Doctor Is In, Around the Clock 3Health News:Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Third Quarter Earnings Conference Call on Friday, May 15, 2009 at 11:00 a.m. EDT 2Health News:Matthew Reeve to Run 2009 ING New York City Marathon for Team Reeve 2Health News:Matthew Reeve to Run 2009 ING New York City Marathon for Team Reeve 3Health News:Surgery improves survival for prostate cancer patients younger than 50 2Health News:Bone marrow stem cell co-transplantation prevents embryonic stem cell transplant-associated tumors 2Health News:Palomar Medical to Market Quantel's SINON Tattoo Removal Laser in the United States and Canada 2Health News:Palomar Medical to Market Quantel's SINON Tattoo Removal Laser in the United States and Canada 3Health News:Palomar Medical to Market Quantel's SINON Tattoo Removal Laser in the United States and Canada 4
... Dot Stereo Depth Perception for Both,Gross ... arc) and Fine Depth,Perception. , ,The ... to 40 sec of arc), An ... 100 sec of arc), 1 Pair ...
... Pulsair EasyEye is the only handheld non-contact tonometer ... EasyEye is streamlined, quiet and now, with ... just a gentle puff of air. You can ... demonstration on the patient's hand before you start. ...
The Emit 2000 Phenytoin Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of phenytoin in human serum or plasma. Emit 2000 assays are designed for use with most ...
... 1000 assays are designed for ... IMMULITE 1000, continuous random access ... in both design and operation. ... in a wide variety of ...
Medicine Products: